Status:
ENROLLING_BY_INVITATION
Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19
Lead Sponsor:
Duke University
Collaborating Sponsors:
University of California, San Diego
Conditions:
COVID-19
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this research study is to assess Radiation Oncology healthcare providers (i.e. faculty, residents and advanced practice providers (APPs) implementation and perception of teleh...
Detailed Description
A secondary aim will be to evaluate the rates of acute care during COVID-19 with telehealth in comparison to the rates during our prior Quality Improvement (QI) project (NCT04277650), considering the ...
Eligibility Criteria
Inclusion
- • started outpatient radiation therapy with or without concurrent systemic therapy at Duke Cancer Center during the COVID-19 outbreak
Exclusion
- undergoing total body radiation therapy for hematopoetic stem cell transplantation
- undergoing therapy as inpatient
- completed radiation therapy prior to algorithm execution
Key Trial Info
Start Date :
April 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04357574
Start Date
April 14 2020
End Date
April 1 2026
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Center
Durham, North Carolina, United States, 27710